Latest News in the pharma Industry

Top Stories

UK to change patent laws to attract clinical trials

UK to change patent laws to attract clinical trials

15 Mar 2013

The UK government intends to take steps to attract drug research and development projects back to the UK.

Read more 
Apposition III clinical trials show low mortality rates

Apposition III clinical trials show low mortality rates

11 Mar 2013

The Stentys Self-Apposing Stent clinical trials show low death rates in patients following severe heart attack.

Read more 
Drug formulation developer Dyax announces board changes

Drug formulation developer Dyax announces board changes

11 Mar 2013

The executive vice president chief operating officer of the company, which specialises in drug formulations for unmet medical needs, is leaving for other opportunities.

Read more 
Rheumatoid arthritis clinical trial to continue

Rheumatoid arthritis clinical trial to continue

8 Mar 2013

Drug formulation PRTX-100 passed a scheduled interim data safety monitoring committee meeting.

Read more 
OncoMed begins Phase 1 clinical trial of stem cell drug

OncoMed begins Phase 1 clinical trial of stem cell drug

8 Mar 2013

OMP-52M51 is a therapeutic that targets cancer stem cells.

Read more 
Immune system-enhancing drug could beat colorectal cancer

Immune system-enhancing drug could beat colorectal cancer

7 Mar 2013

Tests involving the delivery of an immune system-enhancing drug to patients suffering from colorectal cancer have shown promise.

Read more 
Abbott completes separation into two independent companies

Abbott completes separation into two independent companies

1 Mar 2013

A new independent company called AbbVie has been formed to take forward Abbott's research-based pharmaceuticals business.

Read more 
Saudi Arabia pharma market to reach $4.7bn by 2016

Saudi Arabia pharma market to reach $4.7bn by 2016

1 Mar 2013

Saudi Arabia is one of the largest pharmaceutical markets in the Middle East and is due to experience steady growth.

Read more 
Novartis names Dr Joerg Reinhardt as new chairman

Novartis names Dr Joerg Reinhardt as new chairman

27 Feb 2013

Dr Joerg Reinhardt will be the new chairman of Novartis, succeeding Dr Daniel Vasella.

Read more 
OvaSciences announced 2012 financial results

OvaSciences announced 2012 financial results

25 Feb 2013

OvaSciences enjoyed a strong year with most of its R&D spend coming on CROs for a major new trial.

Read more 
Ligand receives milestone payment in development of RE-021

Ligand receives milestone payment in development of RE-021

25 Feb 2013

Development of the clinical candidate RE-021 is being handled by Retrophin, which also has commercialisation rights.

Read more 
Digital Pharma Experience set for Prague

Digital Pharma Experience set for Prague

20 Feb 2013

The Digital Pharma Experience takes place in Prague in May.

Read more